Institutional members access full text with Ovid®

Share this article on:

ACTIVE EPIDEMIOLOGIC SURVEILLANCE OF PNEUMONIA AND INVASIVE PNEUMOCOCCAL DISEASE IN AMBULATORY AND HOSPITALIZED INFANTS IN CORDOBA, ARGENTINA

Tregnaghi, Miguel MD*; Ceballos, Ana MD*; Rüttimann, Ricardo MD†; Ussher, Jose MD*; Tregnaghi, Pablo MD*; Peeters, Pascal MD‡; Hausdorff, William P. PhD‡

Pediatric Infectious Disease Journal: April 2006 - Volume 25 - Issue 4 - pp 370-372
doi: 10.1097/01.inf.0000208368.67448.51
Brief Reports

Active surveillance of ambulatory and hospitalized children 2–23 months old in Cordoba, Argentina for invasive pneumococcal disease and radiographically confirmed “obvious” pneumonia revealed annual incidences of 206.8 and 2422 cases, respectively, per 100,000 children. The invasive pneumococcal disease incidence was substantially higher than those previously reported from Latin America and Europe.

From the *Centro de Desarrollo de Proyectos Avanzados, Cordoba, Argentina; †GlaxoSmithKline Biologicals, Buenos Aires, Argentina; and ‡GlaxoSmithKline Biologicals, Rixensart, Belgium

Accepted for publication November 8, 2005.

Supported by GlaxoSmithKline Biologicals. Dr M. Tregnaghi has served as a consultant to and has received research grants from GlaxoSmithKline Biologicals, which has a pneumococcal conjugate vaccine program. Drs Caballos, Ussher and P. Tregnaghi are employed by CDEPAP, which has received support from GlaxoSmithKline Biologicals.

E-mail ricardo.w.ruttimann@gsk.com. Reprints not available.

© 2006 Lippincott Williams & Wilkins, Inc.